In recent work, authors reported that specific inhibition of MAGL, but not FAAH, protects from striatal DA depletion in an MPTP/probenecid-based mouse model of PD [139], possibly suggesting a role for 2-AG in PD. This evidence concerns the gene MGLL and Parkinson disease.